| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |